Skip to main content

Spinoff NeuroGate Receives $25K Award for Anti-Seizure Drug

January 3, 2014

NeuroGate Therapeutics, a pharmaceutical spinoff company founded by UNC Eshelman School of Pharmacy professor Harold Kohn, PhD, has received a $25,000 Epilepsy Innovation Seal of Excellence Award from the Epilepsy Foundation to support its development of NGT-168, a potential new … Read more

School Spinoff NeuroGate Receives $250,000 Grant

January 8, 2013

NeuroGate Therapeutics, a pharmaceutical spinoff company founded by UNC Eshelman School of Pharmacy professor Harold Kohn, PhD, has received a $250,000 Small Business Technology Transfer grant from the National Institute of Neurological Disorders and Stroke. Founded in 2011, Neurogate has … Read more